# FOS Capital Partners

Investor in Montreal, Quebec, Canada

## About FOS Capital Partners

FOS Capital is a private investment firm dedicated to identifying and supporting highly innovative, emerging Healthcare Technology companies in North America.

We work closely with our cooperation partner FOS Advisors in New York, whose team provides consulting and transaction advisory services to emerging and expanding companies in the Med-Tech Industry in North America and those seeking to enter the North American market.

With Offices in Montreal and New York, FOS Capital supports emerging Healthcare Technology companies with advice and capital. We are solely focused on the Medical Technology sector and provide emerging and expanding businesses based in the USA or Canada, that exhibit high growth potential around clear medical benefits or potential to otherwise benefit the Healthcare Industry, with our full support.

We strive to build and realize value in all of the business ventures we are involved in, utilizing our sector expertise and rigorous, disciplined investment processes.

## People

- **Arndt-Oliver Welsch-Lehmann**, Managing Partner

## Key Facts

- **Location:** Montreal, Quebec
- **Country:** Canada
- **Investor Type:** Venture Capital
- **Founded:** 2012

## Investment Industries

- Medical/Healthcare
- Other

## How to Contact

Direct messaging, this investor's website, and their LinkedIn profile are available with a paid Ask For Funding plan.

- [See plans and pricing](https://askforfunding.com/pricing)
- Already on a paid plan? [Log in](https://askforfunding.com/users/sign_in)

## More on Ask For Funding

- Full profile: https://askforfunding.com/investor/fos-capital-partners
- More investors: [Medical Investors in Quebec](https://askforfunding.com/site/angel-investors/quebec/medical)
- Find more investors: https://askforfunding.com/search/investors

Ask For Funding (AskForFunding.com) connects entrepreneurs with angel investors, private investors and venture capital firms in the United States, Canada and Australia.